Malgorzata Kubicka

Bydgoszcz, KP 85094, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Soluble Hemojuvelin and Ferritin: Potential Prognostic Markers in Pediatric Hematopoietic Cell Transplantation.

Soluble Hemojuvelin and Ferritin: Potential Prognostic Markers in Pediatric Hematopoietic Cell Transplantation.

Journal: Cancers
Published: December 29, 2022

Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas.

Lymphocyte Subpopulations in Patients With Neurofibromatosis Type 1-associated Optic Pathway Gliomas and Plexiform Neurofibromas.

Journal: Anticancer research
Published: September 29, 2019

Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress.

Outcome of Pediatric Acute Lymphoblastic Leukemia: Sixty Years of Progress.

Journal: Anticancer research
Published: July 21, 2019

Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.

Impact of CMV and EBV on Immune Recovery After Allogeneic Hematopoietic Cell Transplantation in Children.

Journal: Anticancer research
Published: July 29, 2018

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.

Phenotype of NK Cells Determined on the Basis of Selected Immunological Parameters in Children Treated due to Acute Lymphoblastic Leukemia.

Journal: Medicine
Published: December 31, 2015

Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.

Drug-resistance Profile in Multiple-relapsed Childhood Acute Lymphoblastic Leukemia.

Journal: Anticancer research
Published: September 27, 2015

Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.

Comparison of prognostic value of in vitro drug resistance and bone marrow residual disease on day 15 of therapy in childhood acute lymphoblastic leukemia.

Journal: Anticancer research
Published: December 11, 2012

Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study.

Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study.

Journal: Leukemia & lymphoma
Published: October 24, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026